India-based Piramal Pharma secures $490m investment from Carlyle Group
The Carlyle Group has signed a deal worth around $490 million with Piramal Enterprises, to acquire a stake of 20% from the Indian conglomerate’s pharma business – Piramal Pharma. The US-based private equity firm will carry out the acquisition through CA Clover Intermediate II Investments, an affiliated entity of CAP V Mauritius, which is an […]